147
A South Africa-focused DNA testing kit that uses saliva samples and polygenic risk scoring to deliver non-diagnostic insights on health traits, pharmacogenomics, and ancestry.

BioCertica is a direct-to-consumer DNA testing platform and Africa's first digital biobank, combining advanced genetic testing with encryption technology to deliver personalised health, lifestyle, and ancestry insights. Users order an at-home saliva kit with prepaid return shipping, and within 6β8 weeks receive results via a secure mobile app. The platform analyses 800,000 genetic markers, enhanced through Polygenic Risk Scoring (PRS) to cover up to 2 million biomarkers β making it the first African company to introduce PRS to consumer DNA testing. Report categories include nutrition & wellbeing, fitness & weight management, skin care, cardiovascular health, mental health, autoimmune & metabolic health, pharmacogenomics, COVID-19 response, and ancestry (not genealogy). Additional reports can be unlocked in-app post-purchase, and results can be shared with practitioners via a dedicated portal. Lab processing is conducted in-house at the University of Stellenbosch. All results are non-diagnostic.
DD Dave found 2 people at Biocertica, including 1 Founder, and 1 VP spread across 2 countries. See how we get product data
Reviews reflect the personal opinions of users. Companies are not able to pay to alter or remove reviews. Verified reviews indicate the reviewer submitted proof of product usage. Learn how reviews work.
No reviews yet. Be the first to review this product.
DD Dave found that Biocertica has raised $2.3M across 3 rounds, backed by 1 investor. Their latest round was a Other in Sep 2023. See how we get product data